We found that deletion of Ng2/Cspg4 at tumor initiation resulted in activation of IGF signaling and a loss of the normal regulation of insulin growth factor–binding proteins, which are known to inhibit IGF signaling and regulate cell proliferation. Here, CSPG4 is linked to neoplasm.